Pediatric ILD program
Research payments
$1,202,810
Through program year 2025, $1,202,810 in research payments was reported against Pediatric ILD program, across 851 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Italia S.p.A.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $7,052 | 2 |
| 2024 | Research | $16,100 | 1 |
| 2023 | Research | $25,305 | 6 |
| 2022 | Research | $370,421 | 30 |
| 2021 | Research | $559,394 | 497 |
| 2020 | Research | $224,382 | 303 |
| 2019 | Research | $156 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robin Deterding Aurora, CO Named on 46 payments
- Gregory Montgomery Indianapolis, IN Named on 46 payments
- Paul Moore Nashville, TN Named on 36 payments
- Geoffrey Kurland Pittsburgh, PA Named on 33 payments
- Jade Tam-Williams Kansas City, MO Named on 29 payments
- Alicia Casey Boston, MA Named on 28 payments
- Christopher Towe Cincinnati, OH Named on 28 payments
- Kristie Ross Cleveland, OH Named on 25 payments
- Aliva De Bronx, NY Named on 25 payments
- Thomas Keens Los Angeles, CA Named on 25 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.